Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Artiva Biotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Artiva Biotherapeutics's enterprise value was -$234.27M on Nov 11, 2026, against -$131.46M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$234.27M | – |
| 2025 | Jan 31, 2025 | -$172.51M | – |
| 2024 | Dec 31, 2024 | -$145.86M | – |
See a number that looks wrong?